Nike stock investors are already pricing in a turnaround that has yet to mature, while Peloton's recovery is well underway.
2 extracted signals · 2 resolved · 0 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 15 Sept 2025, 20:45 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
The analysis compares Peloton (PTON) and Nike (NKE) based on revenue growth, operating cash flow to sales ratio, and return on invested capital (ROIC). Nike's revenue has grown from 36.4 billion to 46.3 billion, a 3.8% CAGR. Peloton's revenue is at 2.5 billion. Nike's operating cash flow to sales ratio has decreased to 8%, while Peloton's has recovered to 13.4%. Nike's ROIC is 15.2% and heading in the wrong direction and Peloton recovered to 7.1%. The discounted cash flow analysis calculates Peloton's intrinsic value per share at $10.62, and forward price to operating cash flow is at 12.73. Nike Intrinsic value per share is 55.67 and forward P/OCF is at 34.44. The analysis suggests Nike is overvalued given a current market price, while Peloton, based on its turnaround and current metrics, is undervalued. Peloton stock better to buy.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.